OTCMCRLBF
Market cap374mUSD
Dec 24, Last price
0.85USD
1D
-1.79%
1Q
-49.10%
IPO
-80.41%
Name
Cresco Labs Inc
Chart & Performance
Profile
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of December 6, 2022, it owned and operated 55 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2018‑01 | 2017‑01 | 2016‑01 | 2015‑01 | |
Income | ||||||||||
Revenues | 770,885 -8.52% | 842,681 2.56% | 821,682 72.53% | |||||||
Cost of revenue | 486,100 | 506,228 | 485,411 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 284,785 | 336,453 | 336,271 | |||||||
NOPBT Margin | 36.94% | 39.93% | 40.92% | |||||||
Operating Taxes | 32,950 | 88,938 | 40,107 | |||||||
Tax Rate | 11.57% | 26.43% | 11.93% | |||||||
NOPAT | 251,835 | 247,515 | 296,164 | |||||||
Net income | (175,522) -18.68% | (215,843) -27.28% | (296,834) 711.86% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 3,088 | 123,962 | ||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 21,233 | 44,936 | 40,720 | |||||||
Long-term debt | 834,209 | 816,851 | 723,743 | |||||||
Deferred revenue | 17,651 | |||||||||
Other long-term liabilities | 30,723 | 14,770 | 7,001 | |||||||
Net debt | 751,283 | 741,218 | 535,008 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 58,564 | 18,741 | 14,487 | |||||||
CAPEX | (55,385) | (86,132) | (97,053) | |||||||
Cash from investing activities | (44,585) | (36,577) | (163,933) | |||||||
Cash from financing activities | (26,907) | (86,643) | 235,005 | |||||||
FCF | 207,185 | 196,638 | 192,583 | |||||||
Balance | ||||||||||
Cash | 103,429 | 119,341 | 223,543 | |||||||
Long term investments | 730 | 1,228 | 5,912 | |||||||
Excess cash | 65,615 | 78,435 | 188,371 | |||||||
Stockholders' equity | 345,537 | 587,683 | 797,736 | |||||||
Invested Capital | 1,073,386 | 1,099,347 | 1,211,803 | |||||||
ROIC | 23.18% | 21.42% | 27.40% | |||||||
ROCE | 24.15% | 26.85% | 22.63% | |||||||
EV | ||||||||||
Common stock shares outstanding | 323,820 | 298,162 | 262,326 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 354,089 | 394,178 | 381,220 | |||||||
EV/EBITDA | ||||||||||
Interest | 63,243 | 58,516 | 52,149 | |||||||
Interest/NOPBT | 22.21% | 17.39% | 15.51% |